MicroRNA analysis of medium/large placenta extracellular vesicles in normal and preeclampsia pregnancies
Journal article
Awoyemi T. et al, (2024), Frontiers in Cardiovascular Medicine, 11
Translation of mechanistic advances in preeclampsia to the clinic: Long and winding road
Journal article
Thadhani R. et al, (2024), The FASEB Journal, 38
Serial placental growth factor-based testing in pre-eclampsia
Journal article
Cerdeira AS. and Karumanchi SA., (2024), The Lancet, 403, 588 - 589
A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles–derived transcriptomic biomarkers in early-onset preeclampsia
Journal article
Awoyemi T. et al, (2023), Frontiers in Cardiovascular Medicine, 10
The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: A historical cohort study.
Journal article
Palma Dos Reis CR. et al, (2023), Acta Obstet Gynecol Scand
Novel therapeutic and diagnostic approaches for preeclampsia.
Journal article
Vatish M. et al, (2023), Curr Opin Nephrol Hypertens, 32, 124 - 133
Preeclampsia and syncytiotrophoblast membrane extracellular vesicles (STB-EVs).
Journal article
Awoyemi T. et al, (2022), Clin Sci (Lond), 136, 1793 - 1807
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial.
Journal article
Kifle MM. et al, (2022), BMC Pregnancy Childbirth, 22
Paracetamol use in pregnancy — neglecting context promotes misinterpretation
Journal article
O’Sullivan J. et al, (2022), Nature Reviews Endocrinology
Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia
Journal article
Cerdeira AS. et al, (2022), American Journal of Obstetrics and Gynecology, 226, 443 - 445
Retroperitoneal leiomyomatosis: a benign outcome of power morcellation with potentially serious consequences
Journal article
Cerdeira AS. et al, (2022), The Lancet, 399, 554 - 554
Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease?
Journal article
Cerdeira AS. et al, (2021), Hypertension, 78, 1395 - 1397
The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia.
Journal article
Cerdeira AS. et al, (2021), Am J Obstet Gynecol
Performance of soluble fms-like tyrosine kinase-1–to–placental growth factor ratio of ≥85 for ruling in preeclampsia within 4 weeks
Journal article
Cerdeira AS. et al, (2021), American Journal of Obstetrics and Gynecology, 224, 322 - 323
In vivo evidence of significant placental growth factor release by normal pregnancy placentas
Journal article
Cerdeira AS. et al, (2020), Scientific Reports, 10
The value of MRI in management of uterine fibroids in pregnancy
Journal article
Cerdeira AS. et al, (2020), European Journal of Obstetrics & Gynecology and Reproductive Biology
One Step Closer to a Cure for Preeclampsia?
Journal article
Cerdeira AS. et al, (2020), Hypertension, 76, 1081 - 1083
Specimen Requirements for Preeclampsia Markers.
Journal article
Smith I. et al, (2020), The journal of applied laboratory medicine, 5, 605 - 607
Predictive Accuracy of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for Preeclampsia in Japan: A Systematic Review
Journal article
Yamazaki T. et al, (2020), Hypertension Research in Pregnancy
Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women
Journal article
Agrawal S. et al, (2019), Hypertension, 74, 1124 - 1135